Singh v. Edwards Lifesciences Corp.

151 Wash. App. 137
CourtCourt of Appeals of Washington
DecidedJuly 6, 2009
DocketNo. 61823-7-I
StatusPublished
Cited by31 cases

This text of 151 Wash. App. 137 (Singh v. Edwards Lifesciences Corp.) is published on Counsel Stack Legal Research, covering Court of Appeals of Washington primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Singh v. Edwards Lifesciences Corp., 151 Wash. App. 137 (Wash. Ct. App. 2009).

Opinion

Grosse, J.

¶1 Washington State follows the Restatement (Second) of Conflict of Laws’ most significant relationship test in determining which state’s law applies to a given issue. Here, the plaintiff underwent a heart transplant after his heart was burned as a result of a defective heart monitor used during surgery in a Washington hospital. The heart monitor was developed by a California-based company that knew of the defect but failed to correct the defect or warn the parties of the potential problem.

¶2 Even though Washington has a strong policy against punitive damages, it has no interest in protecting companies that commit fraud. Where, as here, an entity headquartered in California committed the conduct in California that resulted in the plaintiff’s damages, California had the greater interest in deterring such fraudulent activities. We affirm.

FACTS

¶3 Paramjit Singh went into Providence Everett Medical Center in October 2004 for a relatively routine heart bypass surgery. During surgery, an Edwards Lifesciences’ monitor [141]*141malfunctioned, which turned off the fail-safe devices, causing the Swan-Ganz catheter inserted into Singh’s heart to heat up, destroying his heart.

¶4 After the surgery, doctors were unable to restart Singh’s burned heart and he was kept alive with a mechanical heart device for 11 weeks. He then received a heart transplant at the University of Washington Medical Center. The drugs taken to prevent rejection of his transplanted heart caused Singh to develop blood cancer. Currently that cancer is in remission but he is expected to continue to have severe medical problems associated with both the cancer and his heart transplant.

¶5 Singh filed a products liability claim against Edwards. Providence filed cross claims against the manufacturer for fraud, violation of the Consumer Protection Act (CPA),1 and breach of contract. Both parties sought punitive damages under California law. Edwards admitted its liability for compensatory damages to the plaintiff but contended that Providence shared in that liability.

¶6 The evidence presented at trial revealed that Edwards knew there was a flaw in the heart monitor device as early as 1998. The monitor contained rogue software (Layout 6) that could defeat the fail-safe triggers meant to ensure the catheter would not overheat. The Layout 6 software had originally been installed in an earlier model of the heart monitor. The software was subsequently abandoned but never removed. A July 17,1998 memorandum from Edwards’ principal software designer, Glenn Cox, noted the discovery of the bug in the software. At that time, the monitor’s crash was associated with a faulty continuous cardiac output cable attached to a monitor with a bug in the software. The solution proposed and eventually undertaken in 2006 was to remove the Layout 6 software. A release of heart monitors in 2000 did not have the software removed.

¶7 In October 2002, a catheter caught fire during an operation in Japan. Luckily, the catheter had just been [142]*142removed when the incident occurred. The research in California once again associated the heating of the element with the rogue software, Layout 6. Edwards again decided in California not to recall or warn any of the users but instead to remove the software when a monitor came back in for repair.

¶8 At the time of Singh’s surgery, Providence had 11 monitors, 3 of which had been repaired and no longer contained the Layout 6 software bug. Unfortunately, Singh’s surgery involved the use of a monitor that had not needed repair. At the end of the surgery, surgeons discovered the damage only after trying to take Singh off bypass.

¶9 In June 2006, Edwards recalled the monitor after an extensive investigation by the United States Food and Drug Administration. Edwards admitted the monitor malfunctioned during Singh’s operation. In August 2007, Edwards admitted that Layout 6 was a proximate cause of injury to Singh. On January 18, 2008, Edwards admitted its liability for compensatory damages to Singh but contended that Providence shared in that liability by its use of a defective cable with the monitor.

¶10 The jury returned a verdict in favor of the Singh family for $31,750,000 and awarded punitive damages under California law. The jury allocated 99.9 percent of the fault to Edwards and 0.1 percent of the fault to Providence. The jury awarded Providence compensatory damages in the amount of $210,000. The jury also found that Edwards’ conduct was malicious and, under California law,2 awarded punitive damages in the amount of $8,350,000 to Singh and $100,000 to Providence. In addition to the compensatory damages awarded to Singh and his family, the jury found Edwards had committed fraud, violated the CPA, and breached its contracts with Providence.

¶11 Edwards appeals, arguing that punitive damages should not have been awarded, and that the evidence supporting punitive damages was so entwined with the [143]*143evidence supporting the compensatory damages that the amount awarded for the compensatory damages was higher than it otherwise would have been. Edwards also argues that the jury instruction on insurance should not have been given.

ANALYSIS

Choice of Law

¶12 In resolving conflict of law tort questions, Washington has abandoned the lex loci delicti rule and follows the Restatement (Second) of Conflict of Laws’ most significant relationship test.3 Where a conflict exists, Washington courts decide which law applies by determining which jurisdiction has the most significant relationship to a given issue.4 The court “must evaluate the contacts both quantitatively and qualitatively, based upon the location of the most significant contacts as they relate to the particular issue at hand.”5 The contacts to be evaluated for their relative importance to the issue were set forth in Johnson v. Spider Staging Corp.:6

“(a) the place where the injury occurred,
“(b) the place where the conduct causing the injury occurred, “(c) the domicile, residence, nationality, place of incorporation and place of business of the parties, and
“(d) the place where the relationship, if any, between the parties is centered.”

¶13 In Johnson, scaffolding designed and manufactured in Washington collapsed in Kansas, causing the death of a Kansas resident. The conflict of law issue was whether [144]*144Washington’s law, which allowed unlimited recovery in wrongful death actions, or Kansas’ law, which imposed a $50,000 ceiling, should apply. In holding that Washington law applied, the Johnson court enunciated a two-step analysis to be employed to determine the appropriate choice of law. The court must first evaluate the contacts with each potentially interested state and then, if balanced, evaluate the public policies and governmental interests of the concerned states. The court in Johnson concluded without further comment that the contacts were “evenly balanced.”7 The Johnson court also considered the parties’ justified expectations.8 The Washington corporation sold its products in all 50 states, only a few of which had wrongful death limitations.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Erickson v. Pharmacia LLC
Washington Supreme Court, 2025
LeDoux v. Outliers Inc
W.D. Washington, 2025
Kerry L. Erickson, V. Pharmacia Llc.
548 P.3d 226 (Court of Appeals of Washington, 2024)
Claycamp v. Lalo Trucking Inc
W.D. Washington, 2022
Howard v. Ethicon Inc
W.D. Washington, 2022
White v. Ethicon Inc
W.D. Washington, 2022
Tanessa Desranleau v. Hyland's, Inc.
450 P.3d 1203 (Court of Appeals of Washington, 2019)
J.Y.C.C. v. Doe Run Resources, Corp.
370 F. Supp. 3d 1031 (E.D. Missouri, 2019)
A.O.A. v. Rennert
350 F. Supp. 3d 818 (E.D. Missouri, 2018)
State Of Washington v. D'angelo A. Saloy
Court of Appeals of Washington, 2017

Cite This Page — Counsel Stack

Bluebook (online)
151 Wash. App. 137, Counsel Stack Legal Research, https://law.counselstack.com/opinion/singh-v-edwards-lifesciences-corp-washctapp-2009.